BONE IMPAIRMENT IN ATYPICAL HEMOLYTIC AND UREMIC SYNDROME TREATED BY LONG TERM ECULIZUMAB

被引：0
作者：
Regnier, Maitena [1 ]
Leclerc, Anne-Laure Sellier [1 ,2 ,3 ]
Tenenbaum, Julie [4 ]
Desjonqueres, Marine [1 ]
Fremeaux-Bacchi, Veronique [5 ,6 ]
Farlay, Delphine [7 ]
Bacchetta, Justine [1 ,2 ,3 ,7 ]
机构：
[1] Hosp Civils Lyon, Hop Femme Mere Enfant, Serv Nephrol Rhumatol & Dermatol Pediat, Lyon, France
[2] Hosp Civils Lyon, Hop Femme Mere Enfant, Ctr Reference Malad Renales Rares Nephrogones, Lyon, France
[3] Univ Claude Bernard Lyon 1, Lyon, France
[4] Ctr Hosp Reg Univ Montpellier, Nephrol Pediat, Montpellier, France
[5] Hop Europeen Georges Pompidou, AP HP, Serv Immunol, Paris, France
[6] Paris Univ, Paris, France
[7] Univ Lyon, Fac Med Lyon Est, INSERM, UMR Pathophysiol Diag & Treatments Bone Dis 1033, Lyon, France
来源：
PEDIATRIC NEPHROLOGY | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Su-3MP 114
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [21] Eculizumab treatment of atypical hemolytic uremic syndrome
    Kaplan, Bernard S.
    Ruebner, Rebecca L.
    Copelovitch, Lawrence
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (02): : 167 - 176
  • [22] Eculizumab for Atypical Hemolytic Uremic Syndrome in Pregnancy
    Ardissino, Gianluigi
    Ossola, Manuela Wally
    Baffero, Giulia Maria
    Rigotti, Angelo
    Cugno, Massimo
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (02) : 487 - 489
  • [23] Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice
    de Andrade, Luis Gustavo Modelli
    Contti, Mariana Moraes
    Nga, Hong Si
    Bravin, Ariane Moyses
    Takase, Henrique Mochida
    Viero, Rosa Marlene
    da Silva, Trycia Nunes
    Chagas, Kelem De Nardi
    Pereira Palma, Lilian Monteiro
    PLOS ONE, 2017, 12 (11):
  • [24] Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS)
    Luisa Santangelo
    Giuseppe Stefano Netti
    Sebastiano Mazza
    Francesca Zito
    Valeria Catalano
    Marida Martino
    Diletta Domenica Torres
    Vincenza Carbone
    Elena Ranieri
    Mario Giordano
    Indian Journal of Pediatrics, 2024, 91 : 205 - 205
  • [25] Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings
    Tschumi, S.
    Bucher, B. S.
    Sparta, G.
    Gaspert, A.
    Gugger, M.
    Ardissino, G.
    Simonetti, G. D.
    SWISS MEDICAL WEEKLY, 2010, 140 : 14S - 14S
  • [26] Optimizing the Long-Term Therapy with Eculizumab (ECU) for Atypical Hemolytic Uremic Syndrome (aHUS)
    Santangelo, Luisa
    Netti, Giuseppe Stefano
    Mazza, Sebastiano
    Zito, Francesca
    Catalano, Valeria
    Martino, Marida
    Torres, Diletta Domenica
    Carbone, Vincenza
    Ranieri, Elena
    Giordano, Mario
    INDIAN JOURNAL OF PEDIATRICS, 2024, 91 (02) : 205 - 205
  • [27] Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings
    Tschumi, Sibylle
    Gugger, Mathias
    Bucher, Barbara S.
    Riedl, Magdalena
    Simonetti, Giacomo D.
    PEDIATRIC NEPHROLOGY, 2011, 26 (11) : 2085 - 2088
  • [28] Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histological findings
    Sibylle Tschumi
    Mathias Gugger
    Barbara S. Bucher
    Magdalena Riedl
    Giacomo D. Simonetti
    Pediatric Nephrology, 2011, 26 : 2085 - 2088
  • [29] Case Report: Benefits and Challenges of Long-term Eculizumab in Atypical Hemolytic Uremic Syndrome
    Cullinan, Noelle
    Gorman, Kathleen Mary
    Riordan, Michael
    Waldron, Mary
    Goodship, Timothy H. J.
    Awan, Atif
    PEDIATRICS, 2015, 135 (06) : E1506 - E1509
  • [30] Gemcitabine-Associated Atypical Hemolytic-Uremic Syndrome Treated with Eculizumab
    Plesa, A.
    Suarez, A.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2020, 73 (01) : 77 - 78
12345